Corbus Pharmaceuticals Holdings (CRBP) EBT Margin Growth (1y) (2016 - 2021)
Corbus Pharmaceuticals Holdings (CRBP) EBT Margin Growth (1y) (2016 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -1,532.00 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1,558.00 |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 133.67 Mn | 105.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -1.15 Mn |
| Jun 30, 2021 | 108,467.00 |
| Mar 31, 2021 | -68,913.00 |
| Dec 31, 2020 | -130,397.00 |
| Sep 30, 2020 | -180,296.00 |
| Jun 30, 2020 | -1.33 Mn |
| Mar 31, 2020 | -30,146.00 |
| Dec 31, 2019 | 872,462.00 |
| Sep 30, 2019 | 38,333.00 |
| Jun 30, 2019 | 142,807.00 |
| Mar 31, 2019 | -16,183.00 |
| Sep 30, 2018 | -47,291.00 |
| Jun 30, 2018 | 66,002.00 |
| Mar 31, 2018 | -65,100.00 |
| Sep 30, 2017 | -15,011.00 |
| Jun 30, 2017 | -102,482.00 |
| Mar 31, 2017 | 15,501.00 |
| Sep 30, 2016 | 60,422.00 |
| Jun 30, 2016 | 119,951.00 |